[Essential hypertension: current therapeutic approach].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002908:Chronic Disease; D004038:Diet, Reducing; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D013722:Teprotide; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D004791:Enzyme Inhibitors; D009842:Oligopeptides; D013565:Sympatholytics; D014665:Vasodilator Agents; D013722:Teprotide
Ipertensione essenziale: attuale approccio terapeutico.